Trial of Local Vasopressing Chemotherapy With Liposome-Adm (Lip-Adm) + Angiotensin II (AT II) for Progressive Breast Cancer.

Drug Delivery System - Japan
doi 10.2745/dds.3.262
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Society of Drug Delivery System

Related search

Intraarterial Infusion Chemotherapy for Irresectable Pancreatic Cancer by Using Angiotensin Ii and Prostaglandin E1

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
1984English

Local Radiotherapy Alone Following Neoadjuvant Chemotherapy and Surgery in Combined Clinical Stage II and III Breast Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2016English

Potential Therapeutic Targets for Oral Cancer: ADM, TP53, EGFR, LYN, CTLA4, SKIL, CTGF, CD70

PLoS ONE
Multidisciplinary
2014English

Adrenomedullin and Arterial Stiffness: Integrative Approach Combining Monocyte ADM Expression, Plasma MR-Pro-ADM, and Genome-Wide Association Study

Circulation: Cardiovascular Genetics
2014English

Developments in Cancer Chemotherapy Volume II

British Journal of Cancer
Cancer ResearchOncology
1990English

A Phase II Trial of Erlotinib in Combination With Bevacizumab in Patients With Metastatic Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Angiotensin II Type 1 Receptor (AT-1R) Expression Correlates With VEGF-A and VEGF-D Expression in Invasive Ductal Breast Cancer

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2012English

Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2018English

Intrarenal Angiotensin II Augmentation in Angiotensin II Dependent Hypertension.

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy